Originally published In Press as doi:10.1074/mcp.M800145-MCP200 on September 29, 2008.
Molecular & Cellular Proteomics 8:232-244, 2009.
© 2009 by The American Society for Biochemistry and Molecular Biology, Inc.
Research
Glycosylation Specific for Adhesion Molecules in Epidermis and Its Receptor Revealed by Glycoform-focused Reverse Genomics *,S
Rie Uematsu ,
Yasuro Shinohara , ,
Hiroaki Nakagawa ,
Masaki Kurogochi ,
Jun-ichi Furukawa ,
Yoshiaki Miura ,
Masashi Akiyama¶,
Hiroshi Shimizu¶ and
Shin-Ichiro Nishimura ,||
From the Graduate School of Advanced Life Science, Hokkaido University, Sapporo 001-0021, Japan and ¶ Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo 060-8638 Japan
Glycosylation of proteins greatly affects their structure and function, but traditional genomics and transcriptomics are not able to precisely capture tissue- or species-specific glycosylation patterns. We describe here a novel approach to link different "omics" data based on exhaustive quantitative glycomics of murine dermis and epidermis. We first examined the dermal and epidermal N-glycome of mouse by a recently established glycoblotting technique. We found that the Gal 1–3Gal epitope was solely expressed in epidermis tissue and was preferentially attached to adhesion molecules in a glycosylation site-specific manner. Clarified glycomic and protemic information combined with publicly available microarray data sets allowed us to identify galectin-3 as a receptor of Gal 1–3Gal epitope. These findings provide mechanistic insight into the causal connection between the genotype and the phenotype seen in 3GalT-1-deficient mice and transgenic mice expressing endo-β-galactosidase C. Because humans do not possess the Gal 1–3Gal structure on their tissues, we further examined the human dermal and epidermal N-glycome. Comparative glycomics revealed that the GalNAcβ1–4GlcNAc (N,N'-diacetyllactosediamine) epitope, instead of the Gal 1–3Gal epitope, was highly expressed in human epidermis.
To whom correspondence may be addressed: Graduate School of Advanced Life Science, Frontier Research Center for Post-Genomic Science and Technology, Hokkaido University, Sapporo 001-0021, Japan. Tel.: 81-11-706-9043; Fax: 81-11-706-9042; E-mail: yshinohara{at}glyco.sci.hokudai.ac.jp
|| To whom correspondence may be addressed: Graduate School of Advanced Life Science, Frontier Research Center for Post-Genomic Science and Technology, Hokkaido University, Sapporo 001-0021, Japan. Tel.: 81-11-706-9043; Fax: 81-11-706-9042; E-mail: shin{at}glyco.sci.hokudai.ac.jp

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2009 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|